Search

everythinglearnresearchcommunity

for

Search:↓

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

No medications for alcohol dependence have been approved for marketing yet.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The film-trigger applicator improves microneedle skin delivery and drug efficiency using simple finger force.

Local hypobaric pressure can significantly improve drug delivery through the skin.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Sponges made of soy protein and β-chitin with human cells from hair or fat can speed up healing of chronic wounds.

Intermittent compression therapy is safe and doesn't harm tissue.

PIEZO1 helps keep hair follicle stem cells inactive, affecting hair growth.

The hydrogel helps bone growth and healing in jaw and facial defects.

The developed system could effectively treat hair loss and promote hair growth.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Common skin conditions can greatly affect a person's mental health and social life.

Nephronectin helps attach muscle cells to hair follicles.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Seaweeds contain beneficial compounds with potential uses in food, cosmetics, and health, but more research is needed to improve extraction and safety.

Quick, accurate minoxidil measurement in hair loss products using photometric flow titration.

Three cost-effective methods accurately measure finasteride in pharmaceuticals, better than current techniques.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.